BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-971@pharmaconomics
DTSTAMP:20260707T034539Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:DYN Phase 2 — z-basivarsen (estimated date)
DESCRIPTION:Phase 2 trial results for z-basivarsen in myotonic dystrophy type 1 are due ~ Mar 31\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1818794/000119312526254597/dyn-20260603.htm\n\nTrack it: https://www.pharmaconomics.com/e/971
URL:https://www.pharmaconomics.com/e/971
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:DYN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR